GSK plc (LON:GSK)

GSK plc Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3,870	2,936	3,723	4,274	6,292
Short-Term Investments	381	450	750	614	480
Trading Asset Securities	75	2,302	4,252	77	63
Cash & Short-Term Investments	4,326	5,688	8,725	4,965	6,835
Cash Growth	-23.95%	-34.81%	75.73%	-27.36%	16.92%
Accounts Receivable	5,563	5,905	5,452	6,246	5,549
Other Receivables	1,005	1,081	969	1,214	1,302
Receivables	6,575	6,995	6,432	7,478	6,862
Inventory	5,669	5,498	5,146	5,783	5,996
Prepaid Expenses	390	355	343	315	359
Other Current Assets	37	108	123	133	195
Total Current Assets	16,997	18,644	20,769	18,674	20,247
Property, Plant & Equipment	10,073	9,957	9,620	10,672	11,006
Long-Term Investments	1,232	1,219	1,575	2,276	3,496
Goodwill	6,982	6,811	7,046	10,552	10,597
Other Intangible Assets	15,515	14,768	14,318	30,079	29,824
Long-Term Deferred Tax Assets	6,757	6,049	5,658	5,218	4,287
Other Long-Term Assets	1,907	1,557	1,160	1,632	974
Total Assets	59,463	59,005	60,146	79,103	80,431
Accounts Payable	3,462	3,718	3,866	4,535	4,357
Accrued Expenses	4,059	3,911	3,960	4,864	8,664
Short-Term Debt	-	815	1,489	707	1,047
Current Portion of Long-Term Debt	2,181	1,842	2,296	2,691	2,449
Current Portion of Leases	168	156	167	203	230
Current Income Taxes Payable	703	500	471	489	545
Current Unearned Revenue	171	222	299	307	361
Other Current Liabilities	10,953	9,904	10,262	9,874	4,495
Total Current Liabilities	21,697	21,068	22,810	23,670	22,148
Long-Term Debt	13,703	14,154	16,194	19,761	22,538
Long-Term Leases	934	1,051	841	812	887
Long-Term Unearned Revenue	165	254	83	85	21
Long-Term Deferred Tax Liabilities	382	311	289	3,556	3,600
Other Long-Term Liabilities	7,632	7,032	7,254	6,764	6,779
Total Liabilities	46,377	46,210	50,050	57,761	59,623
Common Stock	1,348	1,348	1,347	1,347	1,346
Additional Paid-In Capital	3,473	3,451	3,440	3,301	3,281
Retained Earnings	8,767	7,743	4,792	8,747	7,294
Comprehensive Income & Other	83	805	1,019	1,660	2,666
Total Common Equity	13,671	13,347	10,598	15,055	14,587
Minority Interest	-585	-552	-502	6,287	6,221
Shareholders' Equity	13,086	12,795	10,096	21,342	20,808
Total Liabilities & Equity	59,463	59,005	60,146	79,103	80,431
Total Debt	16,986	18,018	20,987	24,174	27,151
Net Cash (Debt)	-12,660	-12,330	-12,262	-19,209	-20,316
Net Cash Per Share	-3.06	-3.00	-3.00	-4.74	-5.04
Filing Date Shares Outstanding	4,081	4,056	4,034	4,007	3,985
Total Common Shares Outstanding	4,081	4,056	4,034	4,007	3,985
Working Capital	-4,700	-2,424	-2,041	-4,996	-1,901
Book Value Per Share	3.35	3.29	2.63	3.76	3.66
Tangible Book Value	-8,826	-8,232	-10,766	-25,576	-25,834
Tangible Book Value Per Share	-2.16	-2.03	-2.67	-6.38	-6.48
Land	6,116	6,218	6,388	6,948	7,208
Machinery	10,641	10,344	10,481	11,302	11,554
Construction In Progress	2,314	2,092	1,808	1,707	1,864

Source: S&P Global Market Intelligence. Standard template. Financial Sources.